Article info
PDFCommentary
ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play
- Correspondence to Dr Sophie Mouillet-Richard, INSERM-U1138, Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Paris 75006, France; sophie.mouillet-richard{at}parisdescartes.fr
Citation
ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play
Publication history
- Received January 19, 2021
- Revised February 10, 2021
- Accepted February 11, 2021
- First published February 22, 2021.
Online issue publication
February 02, 2022
Article Versions
- Previous version (2 February 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.